HaEmek Medical Center
Afula, 18101, Israel
NCT Number: NCT01553734
The macrolide group of antibiotics can cause QT prolongation, and endanger the patient with life threatening arrythmias. QT prolongation caused by Azythromycin, a relatively new macrolide, is extremely rare, and was not reported in clinical trials. Our hypothesis is that patients hospitalized with severe community acquired pneumonia, usually with multiple comorbid conditions will have a higher rate of QT prolongation, compared to the clinical trials published
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Afula, 18101, Israel
Patients hospitalized with community aquired pneumonia will have their corrected QT measured daily during antibiotic therapy. Concomittant medications and electrolyte abnormalities that cause prolonged QT will be recorded
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Daily, at estimated peak antibiotic level, during index hospitalization
Looking for future studies?
Notify MeHaEmek Medical Center, Israel
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07070271
Infections, Lung Diseases
Giza, Egypt
View Trial DetailsNCT05050825
Acute Febrile Illness, Arbovirus Infections
Fatick, Senegal
View Trial DetailsNCT06911658
Esophagectomy, Infections
Paris, France
View Trial DetailsNCT03586362
Infections, Lung Diseases
Charleston, West Virginia, United States
View Trial Details